Noventra Pharma TirReta (60mg Multi-Dose Pen – Tirzepatide & Retatrutide Blend)

TirReta 60mg Multi-Dose Pen by Noventra Pharma is an advanced peptide formulation combining tirzepatide and retatrutide, designed to support metabolic regulation, appetite control, and overall body composition. This hybrid stack integrates dual incretin activity from tirzepatide with the triple agonist mechanism of retatrutide, creating a multi-layered approach to metabolic optimisation. It is positioned as a next-generation metabolic stack for structured protocols. Key Features: - 60mg combined peptide formulation: tirzepatide + retatrutide - Dual + triple agonist mechanism involving GIP, GLP-1, and glucagon pathways - Supports appetite regulation and reduced caloric intake - Promotes metabolic efficiency and fat loss pathways - Associated with enhanced energy utilisation and body composition - Multi-dose pen for controlled and flexible dosing Suggested Use: Typically administered in controlled doses as part of a structured protocol. Dosing is often introduced gradually and adjusted based on individual response and tolerance. Always follow guidance from a qualified healthcare provider. Storage: Refrigerate at 2–8°C. Do not freeze. Protect from light. Important Information: This product is intended for use under medical supervision only. Due to its advanced multi-pathway mechanism, it is recommended for experienced or structured protocols. Not suitable for individuals with certain medical conditions. Not recommended for persons under 18, pregnant or breastfeeding individuals. Always consult a qualified healthcare provider before use.